Skip to content

Drug interactions

Bosentan + Vinorelbine

Severity: Minor

Bosentan and Vinorelbine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan is a moderate CYP3A4 inducer, and vinorelbine is metabolized mainly by CYP3A4. Induction could reduce vinorelbine exposure and potentially its efficacy.

What this interaction means in plain words

Bosentan and Vinorelbine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bosentan belongs to Miscellaneous; Vinorelbine belongs to Oncology.

Evidence level: Low

Why it happens

Bosentan induction of CYP3A4 may increase hepatic metabolism of vinorelbine.

What to do

No routine dose change is needed; monitor treatment response if the combination is unavoidable.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Vinorelbine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Vinorelbine?

MediHelp rates the interaction as minor. Bosentan and Vinorelbine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Bosentan is a moderate CYP3A4 inducer, and vinorelbine is metabolized mainly by CYP3A4. Induction could reduce vinorelbine exposure and potentially its efficacy.

How serious is the interaction between Bosentan and Vinorelbine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor treatment response if the combination is unavoidable.

What other medicines interact with Vinorelbine?

MediHelp also lists interactions of Vinorelbine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Belatacept. The full list is on the Vinorelbine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in